Dyne Therapeutics, Inc. · NASDAQ:DYN

Friedl-Naderer Johanna sold 228 Dyne Therapeutics, Inc. shares (Form 4)

Traded May 13, 2026 · Filed May 14, 2026

On May 13, 2026, Friedl-Naderer Johanna (Chief Commercial Officer) sold 228 Dyne Therapeutics, Inc. shares at US$18.36 for US$4,186 under a trading plan, leaving 154,353 shares. Filed May 14, 2026 (Form 4).

Sold
228 shares
Price
US$18.36
Value
US$4,186
Holding after
154,353 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 13, 2026Common StockSale228US$18.36154,353Direct

Source

View original at SEC

Related